Follow The Filings

USNA USANA Health Sciences

USANA Health Sciences earnings company data as of 12:00 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 3 Nov EPS 0.11 — —
Rev — — —

Insider trades

Open-market buys and sales by USNA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All USNA insider trades
  • None no insider bought on the open market
  • $991K sold by 9 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Brent Neidig Chief Commercial Officer
    Sale
    $97K 5,002 shares at $19.45 100% of stake
    Traded Jun 16 Filed Jun 18
    ↗
  2. Brent Neidig Chief Commercial Officer
    Sale
    $50K 2,511 shares at $20.10 33% of stake
    Traded Jun 12–15 Filed Jun 16
    ↗
  3. Paul A. Jones Chief People Officer
    Sale
    $103K 5,561 shares at $18.50 100% of stake
    Traded Jun 8 Filed Jun 8
    ↗
  4. John Turman Fleming Director
    Sale
    $44K 2,450 shares at $17.93 37% of stake
    Traded Jun 1 Filed Jun 1
    ↗
  5. Paul A. Jones Chief People Officer
    Sale
    $129K 6,813 shares at $18.95 55% of stake
    Traded May 28 Filed May 29
    ↗
  6. G Doug Iiekking CFO
    Sale
    $101K 5,360 shares at $18.75 100% of stake
    Traded May 27 Filed May 28
    ↗
  7. Gilbert A Fuller Director
    Sale
    $20K 1,057 shares at $18.66 100% of stake
    Traded May 22 Filed May 26
    ↗
  8. Joshua Foukas Chief Legal Officer
    Sale
    $75K 3,791 shares at $19.82 100% of stake
    Traded May 7 Filed May 8
    ↗
  9. Gilbert A Fuller Director
    Sale
    $18K 1,058 shares at $17.00 100% of stake
    Traded Mar 20 Filed Mar 20
    ↗
  10. Peter Benedict Chief Information Officer
    Sale
    $88K 4,553 shares at $19.38 100% of stake
    Traded Mar 3 Filed Mar 3
    ↗
  11. Joshua Foukas Chief Legal Officer
    Sale
    $95K 4,461 shares at $21.35 100% of stake
    Traded Feb 20 Filed Feb 23
    ↗
  12. Peter Benedict Chief Information Officer
    Sale
    $56K 2,673 shares at $20.95 100% of stake
    Traded Dec 10, 2025 Filed Dec 11, 2025
    ↗
  13. David Mulham Mulham Chief Sales Officer
    Sale
    $18K 873 shares at $21.00 9.4% of stake
    Traded Dec 10, 2025 Filed Dec 11, 2025
    ↗
  14. Frederic J Winssinger Director
    Sale
    $38K 2,000 shares at $19.21 25% of stake
    Traded Nov 10, 2025 Filed Nov 10, 2025
    ↗
  15. Gilbert A Fuller Director
    Sale
    $23K 1,057 shares at $21.48 100% of stake
    Traded Nov 3, 2025 Filed Nov 4, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 59 option exercises and 43 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 9 shown.

Filed Form Detail Links
8-K 1.01,2.03,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
DEF 14A Filing Doc
SCHEDULE 13D/A — Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.